Burning Rock Biotech Limited NASDAQ:BNR Burning Rock Biotech Limited, whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 273,000 tissue and liquid-based tests completed cumulatively, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.

Location: | Website: www.brbiotech.com | Industry: Diagnostic Imaging Centers | Sector: Health Care and Social Assistance